ACVR1 and neoplasm: However, when mutated, it encodes a serine/threonine kinase (ALK2) receptor which has an enhanced sensitivity to the ligand activin A, and therefore impacts the dysregulation of the BMP/SMAD pathway, increasing tumor proliferation.